Literature DB >> 29268338

Circulating tumor cells in lung cancer: cluster circulating tumor cells as hybrid epithelial-mesenchymal transition/mesenchymal-epithelial transition (E/M).

Noriyoshi Sawabata1.   

Abstract

Entities:  

Year:  2017        PMID： 29268338      PMCID： PMC5723813          DOI： 10.21037/jtd.2017.09.63

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  24 in total

1.  Clinical implications of the margin cytology findings and margin/tumor size ratio in patients who underwent pulmonary excision for peripheral non-small cell lung cancer.

Authors:  Noriyoshi Sawabata; Hajime Maeda; Akihide Matsumura; Mitsunori Ohta; Meinoshin Okumura
Journal:  Surg Today       Date:  2011-11-10       Impact factor: 2.549

2.  Prognostic value of the new IASLC/ATS/ERS classification of clinical stage IA lung adenocarcinoma.

Authors:  Shuji Murakami; Hiroyuki Ito; Norifumi Tsubokawa; Takahiro Mimae; Shinsuke Sasada; Tomoharu Yoshiya; Yoshihiro Miyata; Tomoyuki Yokose; Morihito Okada; Haruhiko Nakayama
Journal:  Lung Cancer       Date:  2015-07-02       Impact factor: 5.705

3.  A new device for rapid isolation by size and characterization of rare circulating tumor cells.

Authors:  Isabelle Desitter; Bella S Guerrouahen; Naoual Benali-Furet; Janine Wechsler; Pasi A Jänne; Yanan Kuang; Masahiko Yanagita; Lilin Wang; Jillian A Berkowitz; Robert J Distel; Yvon E Cayre
Journal:  Anticancer Res       Date:  2011-02       Impact factor: 2.480

4.  Cluster Circulating Tumor Cell Is Crucial in Surgically Resected Lung Cancer.

Authors:  Noriyoshi Sawabata
Journal:  J Thorac Oncol       Date:  2017-02       Impact factor: 15.609

5.  Novel approach for detection of isolated tumor cells in pulmonary vein using negative selection method: morphological classification and clinical implications.

Authors:  Soichiro Funaki; Noriyoshi Sawabata; Tomoyuki Nakagiri; Yasushi Shintani; Masayoshi Inoue; Yoshiki Kadota; Masato Minami; Meinoshin Okumura
Journal:  Eur J Cardiothorac Surg       Date:  2011-01-07       Impact factor: 4.191

6.  Cancer stem cells from colorectal cancer-derived cell lines.

Authors:  Trevor M Yeung; Shaan C Gandhi; Jennifer L Wilding; Ruth Muschel; Walter F Bodmer
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-02       Impact factor: 11.205

7.  Perioperative circulating tumor cells in surgical patients with non-small cell lung cancer: does surgical manipulation dislodge cancer cells thus allowing them to pass into the peripheral blood?

Authors:  Noriyoshi Sawabata; Soichiro Funaki; Takeru Hyakutake; Yasushi Shintani; Ayako Fujiwara; Meinoshin Okumura
Journal:  Surg Today       Date:  2016-03-07       Impact factor: 2.549

8.  Frequency and prognostic significance of isolated tumour cells in bone marrow of patients with non-small-cell lung cancer without overt metastases.

Authors:  K Pantel; J Izbicki; B Passlick; M Angstwurm; K Häussinger; O Thetter; G Riethmüller
Journal:  Lancet       Date:  1996-03-09       Impact factor: 79.321

9.  Lung excision of non-small-cell lung cancer leaves cancer cells in residual lobe: cytological detection using pulmonary vein blood.

Authors:  Noriyoshi Sawabata; Soichiro Funaki; Yasushi Shintani; Meinosin Okumura
Journal:  Interact Cardiovasc Thorac Surg       Date:  2015-11-03

10.  Oncogenic ALK regulates EMT in non-small cell lung carcinoma through repression of the epithelial splicing regulatory protein 1.

Authors:  Claudia Voena; Lydia M Varesio; Liye Zhang; Matteo Menotti; Teresa Poggio; Elena Panizza; Qi Wang; Valerio G Minero; Sharmila Fagoonee; Mara Compagno; Fiorella Altruda; Stefano Monti; Roberto Chiarle
Journal:  Oncotarget       Date:  2016-05-31
View more
  1 in total

Review 1.  Circulating Tumor Cells and the Non-Touch Isolation Technique in Surgery for Non-Small-Cell Lung Cancer.

Authors:  Hiroyuki Adachi; Hiroyuki Ito; Noriyoshi Sawabata
Journal:  Cancers (Basel)       Date:  2022-03-11       Impact factor: 6.639
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.